XML 51 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Estimate of the Fair Value of Stock Option
The following assumptions were used to estimate the fair value of stock option for the six months ended June 30, 2020 and 2019:
 
    
Six Months Ended June 30,
 
    
2020
   
2019
 
 
  
(unaudited)
 
Risk-free interest rate
     0.90%      
2.0% - 2.1
%
 
Expected dividend yield
     —         —    
Expected term in years
     7.0      
6.38 - 10.00
 
Expected volatility
     70.0%       80.0%  
Summary of Stock Option Activity
The following table summarizes stock option activity during the six months ended June 30, 2020:
 
    
Stock Options
   
Weighted Average
Exercise Price
    
Weighted Average
Remaining
Contractual Life
(in years)
    
Aggregate
Intrinsic
 
Value
(in
 
thousands)
 
Outstanding as of December 31, 2019
     2,041,205     $ 9.52        7.7      $ 7,857  
Options granted
     867,031       14.81              
Option exercised
     (111,936     7.73        
Options forfeited
     (200,213     12.01               
  
 
 
   
 
 
    
 
 
    
 
 
 
Outstanding as of June 30, 2020 (unaudited)
     2,596,087     $ 11.17        7.8      $ 17,816  
  
 
 
   
 
 
    
 
 
    
 
 
 
Options vested and exercisable as of June 30, 2020 (unaud
i
ted)
     1,138,429     $ 8.34        6.1      $ 11,037  
  
 
 
   
 
 
    
 
 
    
 
 
 
Schedule of RSA Activity
The Company’s RSA activity for the six months ended June 30, 2020 was as follows:
 
    
Number of Shares
    
Weighted Average
Grant Price
 
Unvested as of December 31, 2019
     —        $ —    
Granted
     14,945        14.81  
Vested
     (14,945      14.81  
  
 
 
    
 
 
 
Unvested as of June 30, 2020 (unaudited)
     —        $ —    
  
 
 
    
 
 
 
Summary of the Total Stock-Based Compensation Expense for the Stock Options and RSAs Recorded in the Condensed Consolidated Statements of Operations and Comprehensive Loss
The following table summarizes the total stock-based compensation expense for the stock options and RSAs recorded in the condensed consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2020 and 2019 (in thousands):
 
    
Three Months Ended June 30,
    
Six Months Ended June 30,
 
    
2020
    
2019
    
2020
    
2019
 
    
(unaudited)
    
(unaudited)
 
Cost of products sold
   $ 58      $ 54      $ 166      $ 106  
Research and development
     167        150        378        292  
Selling, general and administrative
     932        599        2,354        964  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation
   $ 1,157      $ 803      $ 2,898      $ 1,362